O

Oragenics

D
OGEN
USD
0.0124
(4.0208%)
Market Closed
1,759.00
Volume
-10.8
EPS
-
Div Yield
-0.042838
P/E
2,718,948.29
Market Cap
Today
-2.1197%
1 Week
1.487%
1 Month
-21.696%
6 Months
-72.212%
12 Months
-91.467%
Year To Date
-94.586%
All Time
-99.888%

Title:
Oragenics

Sector:
Healthcare
Industry:
Biotechnology
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
Do you need help or have a question?